3-N-Butylphthalide
Butylphthalide may increase the anticoagulant activities of Drotrecogin alfa.
Abciximab
Drotrecogin alfa may increase the anticoagulant activities of Abciximab.
Acenocoumarol
Drotrecogin alfa may increase the anticoagulant activities of Acenocoumarol.
Advertisement
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Drotrecogin alfa.
Aloxiprin
The risk or severity of adverse effects can be increased when Aloxiprin is combined with Drotrecogin alfa.
Alprostadil
Alprostadil may increase the anticoagulant activities of Drotrecogin alfa.
Advertisement
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Drotrecogin alfa.
Anagrelide
Anagrelide may increase the anticoagulant activities of Drotrecogin alfa.
Ancrod
Drotrecogin alfa may increase the anticoagulant activities of Ancrod.
Advertisement
Antithrombin III
Drotrecogin alfa may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Drotrecogin alfa may increase the anticoagulant activities of Antithrombin III human.
Apixaban
Drotrecogin alfa may increase the anticoagulant activities of Apixaban.
Aprotinin
The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Aprotinin.
Ardeparin
Drotrecogin alfa may increase the anticoagulant activities of Ardeparin.
Argatroban
Drotrecogin alfa may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Drotrecogin alfa may increase the anticoagulant activities of Argatroban.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Drotrecogin alfa.
Azelastine
Azelastine may increase the anticoagulant activities of Drotrecogin alfa.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Drotrecogin alfa.
Becaplermin
Drotrecogin alfa may increase the anticoagulant activities of Becaplermin.
Bivalirudin
Drotrecogin alfa may increase the anticoagulant activities of Bivalirudin.
Cangrelor
Cangrelor may increase the anticoagulant activities of Drotrecogin alfa.
Certoparin
Drotrecogin alfa may increase the anticoagulant activities of Certoparin.
Cilostazol
Cilostazol may increase the anticoagulant activities of Drotrecogin alfa.
Citric Acid
Drotrecogin alfa may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Drotrecogin alfa may increase the anticoagulant activities of Citric Acid.
Clopidogrel
Clopidogrel may increase the anticoagulant activities of Drotrecogin alfa.
Dabigatran Etexilate
Drotrecogin alfa may increase the anticoagulant activities of Dabigatran etexilate.
Dalteparin
Drotrecogin alfa may increase the anticoagulant activities of Dalteparin.
Danaparoid
Drotrecogin alfa may increase the anticoagulant activities of Danaparoid.
Defibrotide
Defibrotide may increase the anticoagulant activities of Drotrecogin alfa.
Desirudin
Drotrecogin alfa may increase the anticoagulant activities of Desirudin.
Dextran
Drotrecogin alfa may increase the anticoagulant activities of Dextran.
Dextran 40
Drotrecogin alfa may increase the anticoagulant activities of Dextran 40.
Dextran 70
Drotrecogin alfa may increase the anticoagulant activities of Dextran 70.
Dextran 75
Drotrecogin alfa may increase the anticoagulant activities of Dextran 75.
Dicumarol
Drotrecogin alfa may increase the anticoagulant activities of Dicoumarol.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Drotrecogin alfa.
Dipyridamole
Dipyridamole may increase the anticoagulant activities of Drotrecogin alfa.
Edetic Acid
Drotrecogin alfa may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Drotrecogin alfa may increase the anticoagulant activities of Edoxaban.
Enoxaparin
Drotrecogin alfa may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Drotrecogin alfa may increase the anticoagulant activities of Enoxaparin.
Epinastine
Epinastine may increase the anticoagulant activities of Drotrecogin alfa.
Epoprostenol
Epoprostenol may increase the anticoagulant activities of Drotrecogin alfa.
Eptifibatide
Eptifibatide may increase the anticoagulant activities of Drotrecogin alfa.
Ethylenediaminetetraacetate
Drotrecogin alfa may increase the anticoagulant activities of Edetic Acid.
Ferulic Acid
Drotrecogin alfa may increase the anticoagulant activities of Ferulic acid.
Fibrinolysis Inhibitor
The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Aprotinin.
Fluindione
Drotrecogin alfa may increase the anticoagulant activities of Fluindione.
Fondaparinux
Drotrecogin alfa may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Drotrecogin alfa may increase the anticoagulant activities of Fondaparinux sodium.
Heparin
Drotrecogin alfa may increase the anticoagulant activities of Heparin.
Hydroxytyrosol
Hydroxytyrosol may increase the anticoagulant activities of Drotrecogin alfa.
Icosapent Ethyl
Icosapent ethyl may increase the anticoagulant activities of Drotrecogin alfa.
Ifenprodil
Ifenprodil may increase the anticoagulant activities of Drotrecogin alfa.
Iloprost
Iloprost may increase the anticoagulant activities of Drotrecogin alfa.
Indobufen
Indobufen may increase the anticoagulant activities of Drotrecogin alfa.
Ketanserin
Ketanserin may increase the anticoagulant activities of Drotrecogin alfa.
Lepirudin
Drotrecogin alfa may increase the anticoagulant activities of Lepirudin.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Drotrecogin alfa.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Drotrecogin alfa.
Milrinone
Milrinone may increase the anticoagulant activities of Drotrecogin alfa.
Nadroparin
Drotrecogin alfa may increase the anticoagulant activities of Nadroparin.
Nimesulide
Nimesulide may increase the anticoagulant activities of Drotrecogin alfa.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Drotrecogin alfa.
Pentaerythritol Tetranitrate
Drotrecogin alfa may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
Drotrecogin alfa may increase the anticoagulant activities of Pentosan Polysulfate.
Pentoxifylline
Pentoxifylline may increase the anticoagulant activities of Drotrecogin alfa.
Phenindione
Drotrecogin alfa may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Drotrecogin alfa may increase the anticoagulant activities of Phenprocoumon.
Prasugrel
Prasugrel may increase the anticoagulant activities of Drotrecogin alfa.
protein C, human
Drotrecogin alfa may increase the anticoagulant activities of Protein C.
protein S, human
Drotrecogin alfa may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Drotrecogin alfa may increase the anticoagulant activities of Protocatechualdehyde.
Resveratrol
Resveratrol may increase the anticoagulant activities of Drotrecogin alfa.
Reviparin
Drotrecogin alfa may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Drotrecogin alfa may increase the anticoagulant activities of Reviparin.
Rivaroxaban
Drotrecogin alfa may increase the anticoagulant activities of Rivaroxaban.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Drotrecogin alfa.
Sevoflurane
Sevoflurane may increase the anticoagulant activities of Drotrecogin alfa.
Ticagrelor
Ticagrelor may increase the anticoagulant activities of Drotrecogin alfa.
Ticlopidine
Ticlopidine may increase the anticoagulant activities of Drotrecogin alfa.
Tirofiban
Tirofiban may increase the anticoagulant activities of Drotrecogin alfa.
Tranilast
Tranilast may increase the anticoagulant activities of Drotrecogin alfa.
Trapidil
Trapidil may increase the anticoagulant activities of Drotrecogin alfa.
Treprostinil
The risk or severity of adverse effects can be increased when Drotrecogin alfa is combined with Treprostinil.
Triflusal
Triflusal may increase the anticoagulant activities of Drotrecogin alfa.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Drotrecogin alfa.
Troxerutin
Drotrecogin alfa may increase the anticoagulant activities of Troxerutin.
Vorapaxar
Vorapaxar may increase the anticoagulant activities of Drotrecogin alfa.
Warfarin
Drotrecogin alfa may increase the anticoagulant activities of Warfarin.
